Evidence map›Paper›PMID 32962180›Full record

ReviewMolecules (Basel, Switzerland)2020

Jianmei Zhang, Stephanie Triseptya Hunto, Yoonyong Yang, Jongsung Lee, Jae Youl Cho

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Growth, Evapotranspiration, Gas Exchange andPlants (Basel, Switzerland) · 2024
    Article
  6. The Meaning of Plants' Names: A New Discovering Approach to Its Medicinal and/or Toxic Properties.Evidence-based complementary and alternative medicine : eCAM · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianmei ZhangDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0003-0817-4809
Stephanie Triseptya HuntoDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.
Yoonyong YangBiological and Genetic Resources Assessment Division, National Institute of Biological Resources, Incheon 22689, Korea.
Jongsung LeeDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0002-5073-2619
Jae Youl ChoDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-8141-9927

Funding

National Research Foundation of Korea 2017R1A6A1A03015642
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicCell SurvivalDrug Screening Assays, AntitumorHumansMacrophagesMedicine, TraditionalPhytochemicalsTabebuiaAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicPhytochemicalsimmunological disordersimmunopharmacologyTabebuia impetiginosaTaheebotraditional uses

Identifiers

PMID32962180
PMCPMC7571111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.